Published articles 2024
Impact of inadequate bowel cleansing in sigmoidoscopy screening.
Randel KR, Schult AL, Botteri E, Nawaz M, Nguyen DH, Holme Ø, Bretthauer M, Hoff G, de Lange T.Scand J Gastroenterol. 2024 Jun 8:1-8. doi: 10.1080/00365521.2024.2364213.
Matta K, Viallon V, Botteri E, Peveri G, Dahm C, Nannsen AØ, Olsen A, Tjønneland A, Elbaz A, Artaud F, Marques C, Kaaks R, Katzke V, Schulze MB, Llanaj E, Masala G, Pala V, Panico S, Tumino R, Ricceri F, Derksen JWG, Nøst TH, Sandanger TM, Borch KB, Quirós JR, Castro-Espin C, Sánchez MJ, Atxega AA, Cirera L, Guevara M, Manjer J, Tin Tin S, Heath A, Touvier M, Goldberg M, Weiderpass E, Gunter MJ, Freisling H, Riboli E, Ferrari P.BMC Med. 2024 May 29;22(1):210. doi: 10.1186/s12916-024-03362-7.
Divergent effects of switching from cytology to HPV-based screening in the Nordic countries.
Partanen VM, Dillner J, Tropé A, Ágústsson ÁI, Lönnberg S, Heinävaara S, Anttila A.Eur J Public Health. 2024 Apr 3;34(2):354-360. doi: 10.1093/eurpub/ckad225.
[Cervical sample-taking in the primary health service].
Gjerde PB, Tollånes MC, Tropé A, Eide ML, Natvik M, Puntervoll HE.Tidsskr Nor Laegeforen. 2023 Jul 25;143(11). doi: 10.4045/tidsskr.23.0066. Print 2023 Aug 15.
Puco K, Fagereng GL, Brabrand S, Niehusmann P, Støre Blix E, Samdal Steinskog ES, Haug Å, Fredvik Torkildsen C, Oppedal IA, Meltzer S, Flobak Å, Johansson KAM, Bjørge L, Hjortland GO, Dalhaug A, Lund JÅ, Gilje B, Grønlie Cameron M, Hovland R, Falk RS, Smeland S, Giercksky Russnes HE, Taskén K, Helland Å; InPreD Consortium; IMPRESS-Norway Consortium.Acta Oncol. 2024 May 23;63:379-384. doi: 10.2340/1651-226X.2024.28322.
Differential levels of circulating RNAs prior to endometrial cancer diagnosis. Rostami S, Rounge TB, Pestarino L, Lyle R, Fortner RT, Haaland ØA, Lie RT, Wiklund F, Bjørge T, Langseth H. Int J Cancer. 2024 May 11. doi: 10.1002/ijc.34951. PMID: 38733362
Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1.3 million women in Norway. Støer, N.C., Vangen, S., Singh, D. et al. Br J Cancer (2024). doi: 10.1038/s41416-024-02590-1
Changes in intrahost genetic diversity according to lesion severity in longitudinal HPV16 samples. Costanzi JM, Stosic MS, Løvestad AH, Ambur OH, Rounge TB, Christiansen IK. J Med Virol. 2024 May;96(5):e29641. doi: 10.1002/jmv.29641.PMID: 38708811
Quadrivalent HPV vaccine effectiveness against cervical intraepithelial lesion grade 2 or worse in Norway: A registry-based study of 0,9 million Norwegian women. Orumaa M, Lahlum EJ, Gulla M, Tota J, Nygård M, Nygård S.J Infect Dis. 2024 Apr 25:jiae209. doi: 10.1093/infdis/jiae209.
Salvage Reirradiation for Locally Recurrent Prostate Cancer: Results From a Prospective Study With 7.2 Years of Follow-Up. Ekanger C, Helle SI, Reisæter L, Hysing LB, Kvåle R, Honoré A, Gravdal K, Pilskog S, Dahl O.J Clin Oncol. 2024 Apr 23:JCO2301391. doi: 10.1200/JCO.23.01391.
Digital Food Frequency Questionnaire Assessing Adherence to the Norwegian Food-Based Dietary Guidelines and Other National Lifestyle Recommendations: Instrument Validation Study. Henriksen HB, Knudsen MD, Hjartåker A, Blomhoff R, Carlsen MH.J Med Internet Res. 2024 Apr 30;26:e53442. doi: 10.2196/53442.
Lifestyle changes in middle age and risk of cancer: evidence from the European Prospective Investigation into Cancer and Nutrition. Botteri E, Peveri G, Berstad P, Bagnardi V, Hoff G, Heath AK, Cross AJ, Vineis P, Dossus L, Johansson M, Freisling H, Matta K, Huybrechts I, Chen SLF, B Borch K, Sandanger TM, H Nøst T, Dahm CC, Antoniussen CS, Tin Tin S, Fournier A, Marques C, Artaud F, Sánchez MJ, Guevara M, Santiuste C, Agudo A, Bajracharya R, Katzke V, Ricceri F, Agnoli C, Bergmann MM, Schulze MB, Panico S, Masala G, Tjønneland A, Olsen A, Stocks T, Manjer J, Aizpurua-Atxega A, Weiderpass E, Riboli E, Gunter MJ, Ferrari P.Eur J Epidemiol. 2024 Feb;39(2):147-159. doi: 10.1007/s10654-023-01059-4.
Phytonutrients and outcomes following breast cancer: a systematic review and meta-analysis of observational studies. van Die MD, Bone KM, Visvanathan K, Kyrø C, Aune D, Ee C, Paller CJ.JNCI Cancer Spectr. 2024 Jan 4;8(1):pkad104. doi: 10.1093/jncics/pkad104.
Characterizations of uveal melanoma patients with three additional primary malignancies. Eide NA, Faber RT, Garred Ø, Sørum Falk R, Robsahm TE.Acta Ophthalmol. 2024 Jan 16. doi: 10.1111/aos.16631.
Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway. Nafisi S, Støer NC, Veierød MB, Randel KR, Hoff G, Löfling L, Bosetti C, Botteri E.
Am J Gastroenterol. 2024 Mar 18. doi: 10.14309/ajg.0000000000002695.
Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, Weinstein SJ, McCullough ML, Eliassen AH, Cook NR, Agnoli C, Almquist M, Black A, Buring JE, Chen C, Chen Y, Clendenen T, Dossus L, Fedirko V, Gierach GL, Giovannucci EL, Goodman GE, Goodman MT, Guénel P, Hallmans G, Hankinson SE, Horst RL, Hou T, Huang WY, Jones ME, Joshu CE, Kaaks R, Krogh V, Kühn T, Kvaskoff M, Lee IM, Mahamat-Saleh Y, Malm J, Manjer J, Maskarinec G, Millen AE, Mukhtar TK, Neuhouser ML, Robsahm TE, Schoemaker MJ, Sieri S, Sund M, Swerdlow AJ, Thomson CA, Ursin G, Wactawski-Wende J, Wang Y, Wilkens LR, Wu Y, Zoltick E, Willett WC, Smith-Warner SA, Ziegler RG.
Eur J Epidemiol. 2023 Jan;38(1):11-29. doi: 10.1007/s10654-022-00921-1.
Serum neurofilament light chain associates with symptom burden in Lyme neuroborreliosis patients: a longitudinal cohort study from Norway. Skarstein I, Ulvestad E, Solheim AM, Vedeler C, Ljøstad U, Mygland Å, Eikeland R, Reiso H, Lorentzen ÅR, Bos SD.
J Neurol. 2024 May;271(5):2768-2775. doi: 10.1007/s00415-024-12237-z.
Associations between lifestyle, health, and clinical characteristics and circulating oxysterols and cholesterol precursors in women diagnosed with breast cancer: a cross-sectional study. Decker NS, Johnson T, Le Cornet C, Behrens S, Obi N, Kaaks R, Chang-Claude J, Fortner RT.Sci Rep. 2024 Feb 29;14(1):4977. doi: 10.1038/s41598-024-55316-x.
Advisory Group recommendations on priorities for the IARC Monographs. Berrington de González A, Masten SA, Bhatti P, Fortner RT, Peters S, Santonen T, Yakubovskaya MG, Barouki R, Barros SBM, Barupal D, Beane Freeman LE, Calaf GM, Dillner J, El Rhazi K, Fritschi L, Fukushima S, Godderis L, Kogevinas M, Lachenmeier DW, Mandrioli D, Muchengeti MM, Niemeier RT, Pappas JJ, Pi J, Purdue MP, Riboli E, Rodríguez T, Schlünssen V, Benbrahim-Tallaa L, de Conti A, Facchin C, Pasqual E, Wedekind R, Ahmadi A, Chittiboyina S, Herceg Z, Kulasingam S, Lauby-Secretan B, MacLehose R, Sanaa M, Schüz J, Suonio E, Zavadil J, Mattock H, Madia F, Schubauer-Berigan MK. Lancet Oncol. 2024 May;25(5):546-548. doi: 10.1016/S1470-2045(24)00208-0.
Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies. Fortner RT, Brantley KD, Tworoger SS, Tamimi RM, Rosner B, Holmes MD, Willett WC, Eliassen AH.Breast Cancer Res Treat. 2024 Apr 9. doi: 10.1007/s10549-023-07238-x.
How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls? Svendsen K, Leithe S, Trewin-Nybråten CB, Balto A, Nes LS, Meland A, Børøsund E, Kiserud CE, Reinertsen KV, Eriksen HR, Gjelsvik YM, Ursin G. Cancers (Basel). 2024.
For tidlig død av ikke-smittsomme sykdommer. Ariansen I, Larsen IK.Tidsskr Nor Laegeforen. 2024 Feb 12;144(2). doi: 10.4045/tidsskr.23.0849.
Incidence and Factors Associated With Second Primary Invasive Melanoma in Norway. Ghiasvand R, Green AC, Veierød MB, Robsahm TE.JAMA Dermatol. 2024 Apr 1;160(4):402-408. doi: 10.1001/jamadermatol.2023.6251.PMID: 38416466
Post-COVID-19 condition symptoms 6-12 months after hospitalisation in Wuhan. Søraas A, Brunvoll SH, Nygaard AB, Dahl JA, Ursin G. Lancet. 2024 Apr 6;403(10434):1336. doi: 10.1016/S0140-6736(24)00414-8. PMID: 38582558
Cumulative incidence of second primary cancers in a large nationwide cohort of Danish cancer survivors: a population-based retrospective cohort study. Kjaer TK, Andersen EAW, Ursin G, Larsen SB, Bidstrup PE, Winther JF, Borre M, Johansen C, Dalton SO. Lancet Oncol. 2024 Jan;25(1):126-136. doi: 10.1016/S1470-2045(23)00538-7. PMID: 38048803
Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic Review Schopf CM, Ramwala OA, Lowry KP, Hofvind S, Marinovich ML, Houssami N, Elmore JG, Dontchos BN, Lee JM, Lee C. J Am Coll Radiol. 2024 Feb;21(2):319-328. doi: 10.1016/j.jacr.2023.10.018.
Women's attitudes and perspectives on the use of artificial intelligence in the assessment of screening mammograms. Sørlien Holen Å, Almenning Martiniussen M, Burns Bergan M, Moshina N, Hovda T, Hofvind S. Eur J Radiol. 2024 Mar 16;175:111431. doi: 10.1016/j.ejrad.2024.111431.
Digital breast tomosynthesis in mammographic screening: false negative cancer cases in the To-Be 1 trial. Moshina N, Gräwingholt A, Lång K, Mann R, Hovda T, Hoff SR, Skaane P, Lee CI, Aase HS, Aslaksen AB, Hofvind S. Insights Imaging. 2024 Feb 8;15(1):38. doi: 10.1186/s13244-023-01604-5.
AI performance by mammographic density in a retrospective cohort study of 99,489 participants in BreastScreen Norway. Bergan MB, Larsen M, Moshina N, Bartsch H, Koch HW, Aase HS, Satybaldinov Z, Haldorsen IHS, Lee CI, Hofvind S. Eur Radiol. 2024 Mar 25. doi: 10.1007/s00330-024-10681-z.
Performance of an Artificial Intelligence System for Breast Cancer Detection on Screening Mammograms from BreastScreen Norway. Larsen M, Olstad CF, Lee CI, Hovda T, Hoff SR, Martiniussen MA, Mikalsen KØ, Lund-Hanssen H, Solli HS, Silberhorn M, Sulheim ÅØ, Auensen S, Nygård JF, Hofvind S. Radiol Artif Intell. 2024 May;6(3):e230375. doi: 10.1148/ryai.230375.
Early performance measures following regular versus irregular screening attendance in the population-based screening program for breast cancer in Norway. Thy JE, Larsen M, Vigeland E, Koch H, Hovda T, Hofvind S. J Med Screen. 2024 Jun;31(2):107-114. doi: 10.1177/09691413231199583.
How do AI markings on screening mammograms correspond to cancer location? An informed review of 270 breast cancer cases in BreastScreen Norway. Koch HW, Larsen M, Bartsch H, Martiniussen MA, Styr BM, Fagerheim S, Haldorsen IHS, Hofvind S. Eur Radiol. 2024 Feb 23. doi: 10.1007/s00330-024-10662-2.
Comparisons of assessment pathways after abnormal mammography screening in Denmark, Norway, and Spain. Jørgensen SF, Sagstad S, Louro J, Román M, Castells X, Hofvind S, Njor S. Breast Cancer Res Treat. 2024 May;205(1):135-145. doi: 10.1007/s10549-023-07219-0.
The epidemiology of multidrug-resistant organisms in persons diagnosed with cancer in Norway, 2008-2018: expanding surveillance using existing laboratory and register data. Danielsen AS, Elstrøm P, Eriksen-Volle HM, Hofvind S, Eyre DW, Kacelnik O, Bjørnholt JV. Eur J Clin Microbiol Infect Dis. 2024 Jan;43(1):121-132. doi: 10.1007/s10096-023-04698-3.
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study. Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK. Eur J Surg Oncol. 2024 Feb;50(2):107938. doi: 10.1016/j.ejso.2023.107938.
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer. Fosså SD, Holck Storås A, Aas K, Børge Johannesen T, Maria Gjelsvik Y, Myklebust TÅ. Eur Urol Open Sci. 2024 Mar 23;63:62-70. doi: 10.1016/j.euros.2024.03.005.
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study. Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T. Acta Oncol. 2024 Mar 19;63:83-94. doi: 10.2340/1651-226X.2024.24970.PMID: 38501768
Survival trends for patients diagnosed with cutaneous malignant melanoma in the Nordic countries 1990-2016: The NORDCAN survival studies. Lundberg FE, Birgisson H, Engholm G, Ólafsdóttir EJ, Mørch LS, Johannesen TB, Pettersson D, Lambe M, Seppä K, Lambert PC, Johansson ALV, Hölmich LR, Andersson TM.Eur J Cancer. 2024 May;202:113980. doi: 10.1016/j.ejca.2024.113980. PMID: 38452724
Dural Sac Cross-sectional area change from preoperatively and up to 2 years after decompressive surgery for central lumbar spinal stenosis: investigation of operated levels, data from the NORDSTEN study. Hermansen E, Myklebust TÅ, Austevoll IM, Hellum C, Storheim K, Banitalebi H, Indrekvam K, Brisby H.Eur Spine J. 2024 Apr 8. doi: 10.1007/s00586-024-08251-4. PMID: 38587545
Preoperative fatty infiltration of paraspinal muscles assessed by MRI is associated with less improvement of leg pain 2 years after surgery for lumbar spinal stenosis. Banitalebi H, Hermansen E, Hellum C, Espeland A, Storheim K, Myklebust TÅ, Indrekvam K, Brisby H, Weber C, Anvar M, Aaen J, Negård A. Eur Spine J. 2024
The Influence of Spinous Process Union on Clinical Outcomes After Spinous Process Osteotomy for Lumbar Spinal Stenosis After 2 Years: A Secondary Analysis From the NORDSTEN-Study. Hagerup S, Brox JI, Banitalebi H, Indrekvam K, Myklebust TÅ, Hermansen E.Int J Spine Surg. 2024 Feb 27:8576. doi: 10.14444/8576. PMID: 38413237
The association between lumbar lordosis preoperatively and changes in PROMs for lumbar spinal stenosis patients 2 years after spinal surgery: radiological and clinical results from the NORDSTEN-spinal stenosis trial. Wänman J, Åkerstedt J, Banitalebi H, Myklebust TÅ, Weber C, Storheim K, Austevoll IM, Hellum C, Indrekvam K, Brisby H, Hermansen E.Eur Spine J. 2024 Feb 22. doi: 10.1007/s00586-024-08137-5. PMID: 38386059
Do patients with lumbar spinal stenosis benefit from decompression of levels with adjacent moderate stenosis? A prospective cohort study from the NORDSTEN study. Tronstad S, Haug KJ, Myklebust TÅ, Weber C, Brisby H, Austevoll IM, Hellum C, Storheim K, Aaen J, Banitalebi H, Brox JI, Grundnes O, Franssen E, Indrekvam K, Solberg T, Hermansen E.Spine J. 2024 Jan 23:S1529-9430(24)00017-2. doi: 10.1016/j.spinee.2024.01.010. Online ahead of print.
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial. Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D, Klint L, Dueland S, Lassen K; Nordic Pancreatic Cancer Trial-1 study group.Lancet Gastroenterol Hepatol. 2024 Mar;9(3):205-217. doi: 10.1016/S2468-1253(23)00405-3. PMID: 38237621 Clinical Trial.
EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study. Helland Å, Myklebust TÅ, Conte S, Frederiksen LE, Aarøe J, Enerly E.Cancer Treat Res Commun. 2024;38:100785. doi: 10.1016/j.ctarc.2023.100785. PMID: 38190787
